The Motley FoolWed, 08 Apr 2026 11:30:19 GMTArcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should KnowARQT-1.61%
Seeking AlphaThu, 26 Feb 2026 17:01:16 GMTArcutis Earnings: Zoryve Dominance And Pipeline Catalysts Drive The Bull CaseARQT-1.61%
Seeking AlphaThu, 26 Feb 2026 06:27:51 GMTArcutis Biotherapeutics, Inc. (ARQT) Q4 2025 Earnings Call TranscriptARQT-1.61%
Zacks Investment ResearchThu, 26 Feb 2026 01:25:44 GMTArcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue EstimatesARQT-1.61%
Seeking AlphaFri, 20 Feb 2026 14:14:56 GMTArcutis After The Double: Hypergrowth Peaks, Compounding RemainsARQT-1.61%
Zacks Investment ResearchWed, 18 Feb 2026 16:05:54 GMTArcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: Should You Buy?ARQT-1.61%
The Motley FoolFri, 06 Feb 2026 10:18:00 GMTThis Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million ExitARQT-1.61%